Maravai Lifesciences Holdings (MRVI) Non-Current Assets (2020 - 2026)

Maravai Lifesciences Holdings' Non-Current Assets history runs 7 years deep, the most recent figure standing at $461.5 million for Q1 2026.

• On a quarterly basis, Non-Current Assets fell 20.91% year-over-year to $461.5 million in Q1 2026; TTM through Mar 2026 was $2.0 billion, a 20.9% decrease from a year earlier, with the FY2025 full-year figure at $474.3 million, down 18.09% from the prior year.
• Non-Current Assets slipped to $461.5 million in Q1 2026 per MRVI's latest filing, from $474.3 million in the prior quarter.
• Across five years, Non-Current Assets topped out at $1.6 billion in Q3 2023 and bottomed at $461.5 million in Q1 2026.
• The 5-year median for Non-Current Assets is $776.8 million (2024), against an average of $967.7 million.
• Across the five-year window, Non-Current Assets jumped 53.75% in 2022 and sank 61.76% in 2024, its largest moves.
• Year by year, Non-Current Assets stood at $1.4 billion in 2022, then plunged by 45.1% to $787.5 million in 2023, then dropped by 26.47% to $579.1 million in 2024, then decreased by 18.09% to $474.3 million in 2025, then dropped by 2.71% to $461.5 million in 2026.
• Per Business Quant, the three latest MRVI Non-Current Assets figures stand at $461.5 million (Q1 2026), $474.3 million (Q4 2025), and $523.3 million (Q3 2025).